Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference

November 10, 2022

https://www.globenewswire.com/news-release/2022/11/10/2553027/0/en/Clearside-Biomedical-to-Participate-in-a-Fireside-Chat-at-the-Stifel-2022-Healthcare-Conference.html

ALPHARETTA, Ga., Nov. 10, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that George Lasezkay, Pharm.D., J.D., Clearside’s President and Chief Executive Officer and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in a Fireside Chat at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022, from 8:35 – 9:05 a.m. Eastern Time, in New York, NY.

Read more at globenewswire.com

Related news for (CLSD)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.